Bibliographic Details
| Title: |
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker. |
| Authors: |
de Santiago, Pamela R., Sato, Sho, Zhang, Stephanie J., Dougher, Meaghan C., Devins, Kyle M., Bilecz, Agnes J., Rayamajhi, Sagar, Mingo, Gabriel, Rendulich, Hannah S., Feng, Yi, Wu, Connie, Taylor, Martin S., Zhuravlev, Yelena, Jung, Euihye, Omran, Dalia K., Wang, Tian-Li, Shih, Ie-Ming, Schwartz, Lauren E., Kim, Sarah, Morgan, Mark A. |
| Source: |
NPJ Precision Oncology; 3/7/2025, Vol. 9 Issue 1, p1-12, 12p |
| Subject Terms: |
RENAL cell carcinoma, MEDICAL sciences, DNA methylation, CANCER invasiveness, HISTONE methylation |
| Abstract: |
Long interspersed element 1 (LINE-1) retrotransposons are repetitive sequences that can move within the genome by an autonomous mechanism. To limit their mutagenic potential, benign cells restrict LINE-1 expression through molecular mechanisms such as DNA methylation and histone modification, but these mechanisms are usually impaired in cancer. Clear cell ovarian carcinoma (CCOC) represents 5–10% of ovarian cancers and is thought to arise from endometriosis. Women with advanced CCOC face poor prognoses, highlighting the importance of understanding early disease pathogenesis. In our study, 33 of 40 cases (over 82%) of CCOC tumors express ORF1p, a LINE-1-encoded protein. We found that LINE-1 de-repression is an early event in CCOC, as ORF1p is enhanced during the transition from typical to atypical endometriosis and persists in invasive cancer. Finally, using single-molecule array (Simoa) assays, we detected ORF1p in patient blood, suggesting it as a potential minimally invasive biomarker for this disease. [ABSTRACT FROM AUTHOR] |
|
Copyright of NPJ Precision Oncology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
